Effect of Dl-3-n-butyphthalid on learning and memory deficiency and hippocampus synaptic long term potentiation in diabetic mice
Ming Gao, Xiaomei Bai, Suxiao Ji, Huiyao Hao, Songyun Zhang
Abstract
Ming Gao, Xiaomei Bai, Suxiao Ji, Huiyao Hao, Songyun Zhang
Abstract
Objective To study the effect and mechanism of Dl-3-n-butylphthalide(NBP) on memory and learning ability in type 2 diabetes model db/db mice. Methods Sixteen male db/db mice were randomly divided into the NBP group and diabetes group, with 8 mice in each group.Eight male db/m mice of the same age were treated as the control group. NBP group was given NBP by gavage, while diabetes group and control group were given equal volume vegetable oil by gavage. After 6 weeks treatment, Morris water maze was used to examine the spatial memory and learning ability of the mice in each group. The changes of long-term potentiation (LTP) in the hippocampus area of mice were detected by electrophysiological techniques. RT-PCR and Western blot were employed to measure expressions of VEGF, caspase-3, and Aβ1-42 in hippocampus of mice. Results Compared with the control group((21.49±4.41)s), average escape latency of day 5 in the diabetes group and NBP group were increased significantly ((51.69±5.45)s, (26.92±4.76)s, t=9.21, 2.35, both P<0.05). Compared with the control group(7.00±0.60), the number of crossing the target platform in the diabetes group and NBP group were decreased significantly(2.34±0.27), (4.95±0.54), t=-6.56, -2.49; both P<0.05). Compared with the control group((255.90±54.24)%), LTP level in hippocampus of the diabetes group and NBP group were significantly decreased(130.97±14.08)%, (176.17±18.96)%, t=-4.25, -2.38; both P<0.05). The relative expression of VEGF, caspase-3, and Aβ1-42 in the diabetes group and NBP group were significantly increased compared with those of the control group (t=4.59, 8.42; 7.36, 3.85; 3.84, 2.11; all P<0.05). Compared with the diabetes group, the escape latency of day 5, the number of crossing the target platform and LTP level were improved in the NBP group (t=-7.25, 4.06, 3.25; all P<0.05). The decreased expression of caspase-3, Aβ1-42 and increased expression of VEGF were reversed after NBP treatment in db/db mice (t=-4.14, -2.31, 3.42; all P<0.05). Conclusion NBP might improve cognitive function and LTP by exerting anti-apoptosis effect through inhibiting the deposition of Aβ1-42 and upregulating VEGF expression in hippocampus of db/db mice. Key words: Type 2 diabetes mellitus; Cognitive function; Dl-3-n-Butyphthalide; VEGF; Aβ1-42; Mice
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the effect and mechanism of Dl-3-n-butylphthalide(NBP) on memory and learning ability in type 2 diabetes model db/db mice. Methods Sixteen male db/db mice were randomly divided into the NBP group and diabetes group, with 8 mice in each group.Eight male db/m mice of the same age were treated as the control group. NBP group was given NBP by gavage, while diabetes group and control group were given equal volume vegetable oil by gavage. After 6 weeks treatment, Morris water maze was used to examine the spatial memory and learning ability of the mice in each group. The changes of long-term potentiation (LTP) in the hippocampus area of mice were detected by electrophysiological techniques. RT-PCR and Western blot were employed to measure expressions of VEGF, caspase-3, and Aβ1-42 in hippocampus of mice. Results Compared with the control group((21.49±4.41)s), average escape latency of day 5 in the diabetes group and NBP group were increased significantly ((51.69±5.45)s, (26.92±4.76)s, t=9.21, 2.35, both P<0.05). Compared with the control group(7.00±0.60), the number of crossing the target platform in the diabetes group and NBP group were decreased significantly(2.34±0.27), (4.95±0.54), t=-6.56, -2.49; both P<0.05). Compared with the control group((255.90±54.24)%), LTP level in hippocampus of the diabetes group and NBP group were significantly decreased(130.97±14.08)%, (176.17±18.96)%, t=-4.25, -2.38; both P<0.05). The relative expression of VEGF, caspase-3, and Aβ1-42 in the diabetes group and NBP group were significantly increased compared with those of the control group (t=4.59, 8.42; 7.36, 3.85; 3.84, 2.11; all P<0.05). Compared with the diabetes group, the escape latency of day 5, the number of crossing the target platform and LTP level were improved in the NBP group (t=-7.25, 4.06, 3.25; all P<0.05). The decreased expression of caspase-3, Aβ1-42 and increased expression of VEGF were reversed after NBP treatment in db/db mice (t=-4.14, -2.31, 3.42; all P<0.05). Conclusion NBP might improve cognitive function and LTP by exerting anti-apoptosis effect through inhibiting the deposition of Aβ1-42 and upregulating VEGF expression in hippocampus of db/db mice. Key words: Type 2 diabetes mellitus; Cognitive function; Dl-3-n-Butyphthalide; VEGF; Aβ1-42; Mice
Key concepts: Long-term potentiation, Hippocampus, Morris water navigation task, Endocrinology, Internal medicine, Medicine, Streptozotocin, Diabetes mellitus